Nancy Pelosi’s positions were influenced by broader market volatility, largely tied to uncertainty around trade tariffs.

Artificial intelligence (AI) transforms oncology by enhancing decision-making, improving patient care, and streamlining ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

The Global AI in Precision Medicine Market is expected to witness a growth rate of 25-30% in the next five ...

Coverage from “Tech Innovations in Oncology,” presented June 19, 2025, by Tennessee Oncology in Nashville, Tennessee. First ...

Tempus AI TEM continues to push the boundaries of precision medicine through a robust pipeline of research and development (R&D) initiatives. In June, the company introduced xM, a liquid biopsy assay ...

Frontier Capital Management, an investment management company, released its “Frontier Small Cap Growth Fund” first quarter ...

LOS ANGELES, July 7, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Tempus AI, Inc. ("Tempus" or "the Company") (NASDAQ: TEM) for violations of securities ...

Tempus AI, Inc. has announced its plan to offer $400 million in convertible senior notes due in 2030, with the potential for ...